Tolerability and effects of rifampicin on the pharmacokinetics of nevirapine and efavirenz, in patients with HIV infections and tuberculosis

Trial Profile

Tolerability and effects of rifampicin on the pharmacokinetics of nevirapine and efavirenz, in patients with HIV infections and tuberculosis

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Nov 2010

At a glance

  • Drugs Efavirenz (Primary) ; Nevirapine (Primary) ; Rifampicin (Primary)
  • Indications HIV infections; Tuberculosis
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top